L-029

Lacosamide solution

1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

• Tapasztalati képlet (Hill-képlet): C₁₃H₁₈N₂O₃
• CAS-szám: 175481-36-4
• Molekulatömeg: 250.29
• MDL-szám: MFCD08272557
• UNSPSC kód: 41116107
• PubChem Substance ID: 329817347
• NACRES: NA.24

Tulajdonságok

• grade: certified reference material
• Minőségi szint: 300
• Forma: liquid
• Jellemzők: Snap-N-Spike^®/Snap-N-Shoot^®
• kiszerelés: ampule of 1 mL
• gyártó/kereskedő neve: Cerilliant^®
• koncentráció: 1.0 mg/mL in acetonitrile
• technika/technikák: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• alkalmazás(ok): clinical testing
• Formátum: single component solution
• tárolási hőmérséklet: −20°C
• SMILES string: CC(N[C@H](COC)C(NCC1=CC=CC=C1)=O)=O
• InChI: 1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1
• Nemzetközi kémiai azonosító kulcs: VPPJLAIAVCUEMN-GFCCVEGCSA-N
• Géninformáció: human ... SCN10A(6336) , SCN11A(11280) , SCN1A(6323) , SCN2A(6326) , SCN3A(6328) , SCN4A(6329) , SCN5A(6331) , SCN7A(6332) , SCN8A(6334) , SCN9A(6335)

Leírás

Általános leírás

A Certified Spiking Solution^® suitable for use in LC/MS or GC/MS applications in clinical toxicology, forensic analysis, urine drug testing, prescription monitoring or pharmaceutical research. Lacosamide is a new antiepileptic drug developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat^®.

Alkalmazás

• Lacosamide solution as a mass spectrometry standard: A recent development in analytical techniques features a UPLC-MS/MS method for determining lacosamide and its metabolites, essential for drug-drug interaction studies. This research underlines lacosamide′s role as a critical pharmaceutical research tool in the study of anti-epileptic drugs and their interactions (Chen et al., 2023).


• Lacosamide as an anticonvulsant in pharmacological research: Investigations on the effects of chronic lacosamide on ovarian tissue in rats highlight the broader physiological impacts of long-term anti-seizure medication use. Such studies are critical for assessing the reproductive safety of anticonvulsants, informing guidelines for their use in women of childbearing age (Kart et al., 2022).

Jogi információk

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Vimpat is a registered trademark of Harris FRC Corporation

Biztonsági adatok

• Piktogramok: GHS02,GHS07
• Figyelmeztetés: Danger
• Figyelmeztető mondatok: H225,H302 + H312 + H332,H319
• Óvintézkedésre vonatkozó mondatok: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P312 - P305 + P351 + P338
• Veszélyességi osztályok: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2
• Tárolási osztály kódja: 3 - Flammable liquids
• WGK: WGK 2
• Lobbanási pont (F): 35.6 °F - closed cup
• Lobbanási pont (C): 2 °C - closed cup